EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic Performance of Second-Generation Fujifilm SILVAMP TB LAM in Nigerian Adults with Presumptive Tuberculosis

Nadiia Tytarenko, John S Bimba iD, Didac Vulcano, Patricia Comella-Del-Barrio iD, Okoedoh Osazuwa, Jacob Creswell iD, José Domínguez

Journal of Clinical Medicine · 23.10.2025 · 14 (21) · 7524

DOI: 10.3390/jcm14217524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.10.2025. Verfasst von Nadiia Tytarenko und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institut d'Investigació Germans Trias i Pujol, CIBER Enfermedades Respiratorias (CIBERES), Universitat Autònoma de Barcelona, Carretera del Canyet, C…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, The Stop TB Partnership TB REACH, European and Developing Countries Clinical Trial Partnership.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tuberculosis (TB) remains a leading cause of death worldwide, with major diagnostic challenges in low-resource settings. Urine-based lipoarabinomannan (LAM) assays provide a non-invasive option, particularly for people living with HIV who may struggle to produce sputum. Fujifilm has developed a second-generation SILVAMP TB LAM assay (FujiLAM v.2) to improve diagnostic performance. This study aimed to evaluate the diagnostic accuracy of FujiLAM v.2 among Nigerian adults with presumptive TB and directly compare it with the first-generation assay (FujiLAM v.1) using the same set of urine samples.

Methods

We conducted a retrospective analysis among Nigerian adults with presumptive TB (n = 178). Stored urine samples collected in Abuja were retested with FujiLAM v.2 and compared with results previously obtained using FujiLAM v.1 on the same specimens. Xpert MTB/RIF and culture served as the reference standard. Sensitivity, specificity, agreement with the reference standard (Cohen’s Kappa), and differences (McNemar’s test) were assessed.

Results

FujiLAM v.2 demonstrated sensitivity of 58.3% and specificity of 97.3%, comparable to FujiLAM v.1 (58.3% and 98.0%, respectively). No significant differences were found between test versions across TB or HIV subgroups (p > 0.05). Overall agreement between assays was 97.1% (κ = 0.80).

Conclusions

FujiLAM v.2 showed diagnostic performance consistent with the first-generation assay, with similar sensitivity and specificity to the earlier version. These findings support its potential as a rapid, non-sputum-based diagnostic tool to complement TB testing in resource-limited settings. Further studies are needed to assess its implementation within TB diagnostic algorithms, including studies with multiple production lots.

Schlagwörter

Stichwörter der Autor:innen

HIVLAMlipoarabinomannantuberculosisurine

Autor:innen und Institutionen

  • Institut d'Investigació Germans Trias i Pujol, CIBER Enfermedades Respiratorias (CIBERES), Universitat Autònoma de Barcelona, Carretera del Canyet, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.
  • Microbiology, Virology and Biotechnology Department, Odesa National I.I. Mechnikov University, 65000 Odesa, Ukraine.
  • Zankli Research Centre and Department of Community Medicine, Bingham University, Karu 961105, Nigeria.
  • Innovations & Grants, Stop TB Partnership, 1218 Geneva, Switzerland.

ORCID-Profile: John S Bimba, Patricia Comella-Del-Barrio, Jacob Creswell

Förderung

  • Instituto de Salud Carlos III
  • The Stop TB Partnership TB REACH
  • European and Developing Countries Clinical Trial Partnership

Zitieren

APA

Tytarenko, N., Bimba, J. S., Vulcano, D., Comella-Del-Barrio, P., Osazuwa, O., Creswell, J., & Domínguez, J. (2025). Diagnostic Performance of Second-Generation Fujifilm SILVAMP TB LAM in Nigerian Adults with Presumptive Tuberculosis. Journal of Clinical Medicine, 14(21), 7524. https://doi.org/10.3390/jcm14217524

Vancouver

Tytarenko N, Bimba JS, Vulcano D, Comella-Del-Barrio P, Osazuwa O, Creswell J, et al. Diagnostic Performance of Second-Generation Fujifilm SILVAMP TB LAM in Nigerian Adults with Presumptive Tuberculosis. Journal of Clinical Medicine. 2025;14(21):7524. doi:10.3390/jcm14217524

BibTeX
@article{Tytarenko2025,
  author = {Tytarenko, Nadiia and Bimba, John S and Vulcano, Didac and Comella-Del-Barrio, Patricia and Osazuwa, Okoedoh and Creswell, Jacob and Domínguez, José},
  title = {Diagnostic Performance of Second-Generation Fujifilm SILVAMP TB LAM in Nigerian Adults with Presumptive Tuberculosis},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {21},
  pages = {7524},
  doi = {10.3390/jcm14217524}
}
Kostenlos starten →